[The evaluation of the reactogenicity, harmlessness and prophylactic efficacy of Grippol trivalent polymer-subunit influenza vaccine administered to schoolchildren].

@article{Elshina2000TheEO,
  title={[The evaluation of the reactogenicity, harmlessness and prophylactic efficacy of Grippol trivalent polymer-subunit influenza vaccine administered to schoolchildren].},
  author={G A El'shina and M. A. Gorbunov and Tagir Bektimirov and N I Lonskaia and Libtx{\vs}e Pavlov{\'a} and A A Nikul'shin and Rakhim M. Khaitov and Aleksei Nekrasov and Alexandra S. Ivanova and Mikhail Matrosovich and N. G. Puchkova},
  journal={Zhurnal mikrobiologii, epidemiologii, i immunobiologii},
  year={2000},
  volume={2},
  pages={50-4}
}
Vaccine "Grippol"--has been developed at the State Research Center--Institute of Immunology. The preparation belongs to new generation vaccines and is a trivalent polymer-subunit vaccine containing the sterile conjugate of influenza virus surface proteins, types A and B, bound with copolymer polyoxidonium. The administration of "Grippol" to children of school age (6-18 years) demonstrated low reactogenicity of the vaccine, its safety and sufficient prophylactic effectiveness. During… CONTINUE READING